NHIA asks for bundled payment
By HME News Staff
Updated Wed April 8, 2020
ALEXANDRIA, Va. - The National Home Infusion Association says CMS's interim final rule doesn't go far enough to preserve access to home infusion therapy.
“In our view, the CMS interim final rule does not establish a practical path forward for the thousands of patients who depend on IV therapies to manage their clinical conditions at home,” the association states.
The NHIA argues that the IFR's expansion of telehealth and broadening of clinical indications for a limited number of Part B DMEPOS drugs won't significantly expand access to home infusion for seniors who need to avoid being exposed to the coronavirus.
Instead, the association makes the case for establishing a bundled payment for professional services, supplies and equipment—similar to the commercial payer model—that is paid to home infusion providers for each day of infusion.
The NHIA says CMS should move quickly to leverage these clinicians and help beneficiaries get the medications they need at home.
“Now more than ever we need practical solutions based on proven methodologies to create home infusion access,” said NHIA President & CEO Connie Sullivan. “This rule will not relieve the burden facing health systems or provide viable alternatives for seniors.”
Comments